Eyegate Pharmaceuticals Inc operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Eyegate Pharmaceuticals Inc with three other
companies in this sector in the United States:
sales of $1.51 million
Adverum Biotechnologies Inc
of which 100%
was Developing and Commercializing Therapeut), and